Tweetovi

Blokirali ste korisnika/cu @gocheval

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @gocheval

  1. proslijedio/la je Tweet
    27. sij

    Join us tomorrow at 4pm in 68-181 to hear about career options in big pharma! The panel includes Christopher Tehlirian from , Jeremy Jenkins from , Dina Sah from , and Nenad Grmusa from .

    Poništi
  2. proslijedio/la je Tweet
    10. pro 2019.

    Convergence Scholars from and learning how to apply everyday in/outside the lab!

    Poništi
  3. proslijedio/la je Tweet

    Tomorrow, 12/10: KI faculty member Michael Yaffe, 's , and 's Mark Erlander talk about how collaboration took a forgotten drug class to a promising clinical trial for . Reserve free tickets:

    Poništi
  4. proslijedio/la je Tweet
    21. stu 2019.

    Beyond honored and humbled to deliver the Lippard lectures at and . Wonder to see old friends and colleagues. It's like coming home. Amazing experience.

    Poništi
  5. 21. stu 2019.

    Looking forward to reading his book too!

    Prikaži ovu nit
    Poništi
  6. 21. stu 2019.

    So excited to be hosting today and hear his incredible story!

    Prikaži ovu nit
    Poništi
  7. proslijedio/la je Tweet
    19. stu 2019.

    Fun times w Convergence Scholars exploring topics w ’s Dr. Prerna Bhargava!

    Poništi
  8. proslijedio/la je Tweet
    22. lis 2019.

    “That was an answer we were looking for — what is making pancreatic tumors resistant to gemcitabine?” says Michael Hemann, assoc. prof. of and . This find "allows us to return to the clinic with improved strategies to treat patients with cancer.”

    Poništi
  9. proslijedio/la je Tweet

    We’re so excited to have North Court (our backyard) renamed in honor of MIT President Emerita Susan Hockfield. Her championship of convergence laid the foundation for this building and will forever change the landscape of cancer research.

    Poništi
  10. proslijedio/la je Tweet
    17. ruj 2019.

    Great talk by at last night's Marble Center seminar! We were also thrilled to host a panel on the Convergence Scholars Program as we open applications for 2019-2020! Postdocs from and can apply here:

    , , i još njih 2
    Poništi
  11. proslijedio/la je Tweet
    22. srp 2019.

    “It’s really the forefront of cancer therapy,” says Michael Hemann, a cancer researcher at and .

    Poništi
  12. proslijedio/la je Tweet
    22. srp 2019.

    Prof. Michael Hemann talked to about how our bodies “coddle” cancer:

    Poništi
  13. 18. lip 2019.

    What an incredible talk by at on mediKanren, the tool he has created combining logical reasoning and biomedical knowledge to come up with new treatment options for patients

    Poništi
  14. 18. lip 2019.

    Excited to be at the 5th annual precision medicine conference

    Poništi
  15. proslijedio/la je Tweet
    10. lip 2019.

    A research team including Prof. Graham Walker, Prof. Michael Hemann, and, has discovered a potential drug that could make tumors more susceptible to chemo. Their results are published in .

    Poništi
  16. proslijedio/la je Tweet
    31. svi 2019.

    Looking for a quick 5 mins read? Right before ? Here is my recommendation!

    , , i još njih 7
    Poništi
  17. proslijedio/la je Tweet
    8. svi 2019.

    Another great networking hour with Convergence Scholars and , , , and

    Poništi
  18. 22. tra 2019.

    Enjoyed hearing more about ’s awesome nonprofit at

    Poništi
  19. proslijedio/la je Tweet
    18. tra 2019.

    A new study from the suggests the substance bathing tumors in the body is quite different from the medium used to grow cancer cells in the lab — a finding that has implications for drug development:

    Poništi
  20. 16. tra 2019.

    "There’s lots of people yelling “in mice” in their heads..." It’s just in mice! This scientist is calling out hype in science reporting via

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·